secwatch.observer — SEC 8-K summary
======================================

Issuer:     Amphastar Pharmaceuticals, Inc. (AMPH)
CIK:        0001297184
Form:       8-K
Filed at:   2023-06-06T23:59:59+00:00
Accession:  0001297184-23-000053
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Amphastar shareholders elect three Class I directors, ratify auditor, approve say-on-pay at 2023 annual meeting
--------------------------------------------------------------------------------

- Floyd F. Petersen, Jacob Liawatidewi, and William J. Peters elected as Class I directors to serve until 2026.
- Ratification of Ernst & Young as independent auditor for FY2023: 42,097,266 for, 585,099 against.
- Advisory vote on executive compensation approved: 37,281,658 for, 1,276,813 against, 4,029,572 broker non-votes.
- All proposals passed; meeting held virtually on June 5, 2023.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1297184/000129718423000053/0001297184-23-000053-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1297184/000129718423000053/amph-20230605x8k.htm
  HTML page:      https://secwatch.observer/filing/0001297184-23-000053

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer